Tammie K. Berry CEO
CEO
Viper Vapor LLC d/b/a Viper Vapor Kelso LLC
1402 Broadway Street, Suite 105
Longview , WA 98632
United States
Tammieberry@msn.com
Kevin@viper-vapor.comFEI 3013924896Issued Aug 23, 2023Center for Tobacco Products
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3013924896.
Violations1
Issue DateAug 23, 2023
Product TypeTobacco
StatusOpen
Letter Details
Firm
Viper Vapor LLC d/b/a Viper Vapor Kelso LLC
Location
Tammie K. Berry CEO
CEO
Viper Vapor LLC d/b/a Viper Vapor Kelso LLC
1402 Broadway Street, Suite 105
Longview , WA 98632
United States
Tammieberry@msn.com
Kevin@viper-vapor.com
FEI Number
3013924896
Country
United States
Issue Date
August 23, 2023
Issuing Office
Center for Tobacco Products
Product Type
Tobacco
Status
Open
Summary
Viper Vapor LLC manufactured and distributed e-liquid tobacco products containing nicotine without obtaining required premarket authorization from the FDA. The company failed to comply with the Family Smoking Prevention and Tobacco Control Act and regulations governing new tobacco products, which mandate premarket review and approval before commercial distribution in the United States. This violation applied to all e-liquid products the company manufactured and offered for sale, including those made with nicotine from any source following the March 2022 expansion of FDA's tobacco product jurisdiction.
Viper Vapor LLC d/b/a Viper Vapor Kelso LLC FDA Warning Letter, August 23, 2023
Talk to a Specialist